Unique ID issued by UMIN | UMIN000018660 |
---|---|
Receipt number | R000021237 |
Scientific Title | Japanese POEMS syndrome with thalidmaide trial for compassionate use |
Date of disclosure of the study information | 2015/08/17 |
Last modified on | 2022/01/11 15:30:42 |
Japanese POEMS syndrome with thalidmaide trial for compassionate use
Japanese POEMS syndrome with thalidmaide trial for compassionate use (JPOST15)
Japanese POEMS syndrome with thalidmaide trial for compassionate use
Japanese POEMS syndrome with thalidmaide trial for compassionate use (JPOST15)
Japan |
Crow-Fukase(POEMS) syndrome
Hematology and clinical oncology | Neurology |
Others
NO
to provide FPF300 in POEMS syndrome for compationate use and to investigate long term safty and efficacy
Safety,Efficacy
Safety:Adverse event during FPF300 treatment
Efficacy:Overall survival
1.Serum VEGF level
2.Motor function(Manual Muscle Test, grip strength,ONLS)
3.Median nerve conducton study (conduction velocity, CMAP amplitude, F-wave latency, SNAP amplitudes), Sural nerve conduction study (SNAP amlitudes and conduction velocity)
4.M protein (immunofixation)
5. Pleural effusion
6. Body weight
Interventional
expanded access
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
FPF300 (thalidomide)100-300mg/day,at bedtime +Dexamethasone 20mg/day (day1-4)
Duration:until the approval of thalidomide for POEMT syndrome
20 | years-old | <= |
Not applicable |
Male and Female
(1) Patients with Crow-Fukase syndrome (confirmed by diagnostic criteria)
(2) Patients aged 20 and older
(3) Patients without severe liver or renal dysfunction
(4) Patients without clinicaly probrematic ECG findings or severe bradycardia which require treatment.
(5) Patients with written informed consent
(6) Patients with informed consent to thalidomide education and risk management system
(1) Patients with the complication which leading to a high risk of severe adversed event by thalidomide (Absolute neutrophil count < 1000, Platelet count< 50000, repeated ileus,severe cardiac arrhythmias)
(2) Female patients who are pregnant, desire childbearing or breastfeeding
(3) Males patients who desire fertility.
(4) Patients with severe complicaitons ( cardiac failure, renal failure liver failure, bleeding enterogastric ulcer, ileus, poorly controlled diabetes)
(5) Patients who allergic to thalidomide
(6) Patients with severe phychiatric disorders
(7) Patients who has been participated any other clinical trial
(8)Patients who are not appropriate to participate to the trial
20
1st name | Satoshi |
Middle name | |
Last name | Kuwabara |
Chiba University, Graduate School of Medicine
Department of Neurology
2608677
Inohana 1-8-1, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan
0432227171
syukari536@chiba-u.jp
1st name | Kanako |
Middle name | |
Last name | Katayama |
Chiba University Hospital
Clinical research center
2608677
Inohana 1-8-1, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan
0432227171
katayama-k@umin.net
Chiba University Graduate School of Medicine
Chiba university hospital
Self funding
Clinical research center, Chiba university hospital
1-8-1 Inohana Chuo-ku Chiba city
0432227171
yamazaki@office.chiba-u.jp
NO
2015 | Year | 08 | Month | 17 | Day |
Unpublished
Completed
2015 | Year | 06 | Month | 25 | Day |
2015 | Year | 07 | Month | 22 | Day |
2015 | Year | 08 | Month | 17 | Day |
2020 | Year | 04 | Month | 01 | Day |
2015 | Year | 08 | Month | 13 | Day |
2022 | Year | 01 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021237
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |